Volume 25, Issue 3 (Autumn 2021)                   2021, 25(3): 191-194 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Madani P S, Mirzadeh M, Rostamian S. The Difference in Immunoglobulin G Levels Between Outpatients and Inpatients With COVID-19. Journal of Inflammatory Diseases. 2021; 25 (3) :191-194
URL: http://journal.qums.ac.ir/article-1-3259-en.html
1- Metabolic Diseases Research Center, Research Institute for Prevention of Non-communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran. , drparisasadatmadani@gmail.com
2- Metabolic Diseases Research Center, Research Institute for Prevention of Non-communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran.
Abstract:   (451 Views)
Background: Coronavirus disease 2019 (COVID-19) has rapidly become a pandemic since it was first reported in late December 2019. Serological reports are of great value to medical specialists in developing health policies. The detection of Immunoglobulin G (IgG) level in COVID-19 patients can specify a preclinical infection or previous exposure to the virus.
Objective: This study aims to assess the IgG rate in patients with COVID-19.
Methods: This is a cross-sectional study on 172 patients with confirmed COVID-19 (having positive PCR test) in Qazvin, Iran in 2020, including 86 inpatients and 86 outpatients. In order to measure the IgG levels, the serum samples were collected 3-5 weeks after onset of their clinical symptoms. Data were statistically analyzed in SPSS software v. 20, considering the significance level of P<0.05.
Results: Of 172 patients, 81(94.2%) inpatients and 74(86%) outpatients tested positive for IgG, while 5(5.8%) inpatients and 10(11.6%) outpatients tested negative for IgG. The mean IgG level in inpatients was significantly higher than in outpatients (P<0.001) 3-5 weeks after a positive PCR test.
Conclusion: The amounts of IgG in the sera of COVID-19 patients 3-5 weeks after the onset of symptoms can help health care authorities develop policies and control strategies by determining the burden of disease, monitoring the spread of disease, and estimating the epidemiological factors.
Article number: 8
Full-Text [PDF 588 kb]   (50 Downloads) |   |   Full-Text (HTML)  (28 Views)  
Type of Study: Short communication | Subject: Infectious Disease

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb